Sodium selenite and sodium selenate are approved inorganic Se (selenium) compounds in human and animal nutrition serving as precursors for selenoprotein synthesis. In recent years, numerous additional biological effects over and above their functions in selenoproteins have been reported. For greater insight into these effects, our present study examined the influence of selenite and selenate on the differential expression of genes encoding non-selenoproteins in the rat liver using microarray technology. Five groups of nine growing male rats were fed with an Se-deficient diet or diets supplemented with 0.20 or 1.0 mg of Se/kg as sodium selenite or sodium selenate for 8 weeks. Genes that were more than 2.5-fold up-or down-regulated by selenite or selenate compared with Se deficiency were selected. GPx1 (glutathione peroxidase 1) was up-regulated 5.5-fold by both Se compounds, whereas GPx4 was up-regulated by only 1.4-fold. Selenite and selenate down-regulated three phase II enzymes. Despite the regulation of many other genes in an analogous manner, frequently only selenate changed the expression of these genes significantly. In particular, genes involved in the regulation of the cell cycle, apoptosis, intermediary metabolism and those involved in Se-deficiency disorders were more strongly influenced by selenate. The comparison of selenite-and selenateregulated genes revealed that selenate may have additional functions in the protection of the liver, and that it may be more active in metabolic regulation. In our opinion the more pronounced influence of selenate compared with selenite on differential gene expression results from fundamental differences in the metabolism of these two Se compounds.
INTRODUCTION
Since the discovery of the essentiality of Se (selenium) five decades ago, this element has been increasingly associated with many biological processes [1] . In contrast with other metal trace elements that interact with proteins as cofactors, the physiological functions of Se derive mainly from the incorporation of Se into the active sites of functional selenoproteins via the co-translational synthesis of selenocysteine [1] . To date, the existence of not less than 33 functional selenoproteins with at least one selenocysteine
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residue has been reported. The best investigated characteristic of Se is its antioxidant role. Six different GPxs (glutathione peroxidases; GPx1-GPx6) and two TrxRs (thioredoxin reductases; TrxR1 and TrxR2) contribute largely to the maintenance of cellular antioxidant defence. The involvement in thyroid metabolism through iodothyronin deiodinase activity represents a further important Se-dependent target [2] . Under conditions of low Se availability, these selenoproteins selectively are down-regulated. Whereas GPx1, exhibiting a high and ubiquitous expression and activity in mammalian tissues, and plasma GPx (GPx3) undergo a rapid and severe down-regulation, gastrointestinal GPx (GPx2) and phospholipidhydroperoxide GPx (GPx4) are far more conserved [3, 4] . Depending on the animal species, a long-term Se deficiency causes liver necrosis and myopathies [5] [6] [7] [8] . Besides the mechanisms of functional selenoproteins, in recent years additional information on Se biochemistry has been obtained. The down-regulation of phase II detoxification enzymes such as GSTs (glutathione transferases) and Afar (aflatoxin B 1 aldehyde reductase) due to adequate Se supply impressively shows the counter regulation of cellular stress response [9, 10] . Anticarcinogenic effects of supranutritive Se dosages, investigated in animal trials and tissue culture experiments, may result from the initiation of proapoptotic mechanisms by the generation of monomethylselenol and high concentrations of reactive oxygen species [11] , or from the response of phosphorylation and signal transduction mechanisms [12] . Other hypotheses suggest the reversion of the hypermethylated DNA of tumour suppressor genes [13] or the reduction of prostaglandin E 2 and cyclo-oxygenase 2 via GPx2 activity to be the underlying mechanisms for the protective effect of Se against colon cancer [14] . However, the results of large placebo-controlled human intervention trials did not support uniquely beneficial effects of supranutritional Se supplementation in the prevention of several cancers [15, 16] . The influence of Se supplementation and selenoprotein activities on obesity, insulin resistance, diabetes and hyperlipidaemia has been the subject of a recent controversial discussion. Whereas only very high supranutritive selenate doses have antidiabetic effects [17] , a high activity of GPx1, as well as a high Se status derived from the permanent intake of Se supplements, has lately been reported to be one possible cause of the accelerated development of obesity, insulin resistance, diabetes and hyperlipidaemia [18] [19] [20] [21] [22] . These important results were the outcome of the abovementioned cancer intervention trials and of large cross-sectional studies [15, [19] [20] [21] . Optimum activities of all functional selenoproteins can be obtained by a daily Se uptake of 30-70 μg in humans and by a concentration of 0.15-0.30 mg of Se/kg of diet in animals. The inorganic Se compounds sodium selenite (+IV) and sodium selenate (+VI) are approved Se additives both in human mineral supplements and in animal feed. Both selenite and selenate have a high absorption rate from the small intestine [23] , but they exhibit some fundamental differences in their absorption mechanism as well as in their intermediary metabolism. There is no doubt that selenite and selenate represent valuable inorganic Se compounds to ensure adequate selenoprotein synthesis [24, 25] . Nevertheless, information is lacking whether and in what way selenite and selenate influence the expression of genes beyond functional selenoproteins. In this context the present study using MA (microarray analysis) as the analytical tool had the following aims: (1) data mining of genes regulated differentially by selenite or selenate supplementation versus a control group with Se deficiency; and (2) exploring genes responding in particular to selenite or selenate supplementation by direct comparison of the selenite and selenate expression profile.
A nutrition trial with healthy growing rats served as the basis for the examination of differential gene expression by selenite and selenate. 45 weanling albino rats (HK 51, strain of the Institute of Animal Nutrition and Nutritional Physiology) were randomly assigned to five groups of nine. The average initial body weight (62.8 + − 4.0 g) did not vary among groups. The rats were fed with a Torula yeast-based diet as described earlier [22] for 8 weeks.
MATERIALS AND METHODS

Rats and diet preparation
The diet was composed according to the current recommendations of the NRC (National Research Council) [26] with the exception of Se. The analysed Se concentration of the basal diet (group 0) was below the detection limit (<0.03 mg of Se/kg of diet). Groups I and II were fed with diets adequate in Se (0.20 mg of Se/kg of diet) either supplemented with sodium selenite (group I) or sodium selenate (group II). The diets of groups III and IV were supplemented with sodium selenite or sodium selenate to a supranutritive Se concentration of 1.0 mg of Se/kg of diet. The rats were kept individually in plastic cages with wood shavings as bedding under standard laboratory conditions (22 • C, 55 % humidity, 12 h light/12 h dark cycles) and had free access to the diet and deionized water. The protocol of the animal experiment was approved by the Regional Council of Giessen and by the animal welfare committee of Giessen University. At the end of the trial, the rats were anaesthetized in a carbon dioxide atmosphere and subsequently decapitated. The liver was removed, frozen in liquid nitrogen and stored at -80
• C until analysis.
Se analysis in diets and liver
Se concentration in the diets and the livers was determined by hydride generation AAS (atomic absorption spectrometry; Unicam PU 9400 X; PU 3960 X) as reported previously [27] . Certified samples from the NIST (National Institute of Standard and Technology; soft winter wheat flour, NIST no. 8438, and bovine liver, NIST no. 1577 b) served as reference material for Se determination in the different matrices.
RNA extraction and MA
The analysis of differentially expressed genes was performed using '10k rat oligoarrays' from MWG (Ebersberg, Germany). On one single MA slide, short nucleotide sequences of 9715 different rat genes are spotted in duplicate, which allows the cohybridization of RNA samples from two experimental groups on one MA slide. RNA was extracted from the liver of five rats per group by the phenol/chloroform/guanidine thiocyanate extraction protocol [28] , further purified by a DNase I digest and pooled. Direct Cy3 or Cy5 labelling of single-stranded DNA by synthesis from 100 μg of total RNA, MA hybridization and scanning, background correction and data analysis up to comparable expression values were performed by MWG-BIOTECH AG (Ebersberg, Germany; http://www.mwg-biotech.com/). The samples were assigned to the six microarrays as follows: Microarray 1: Cy3 (group 0), Cy5 (group I); Microarray 2: Cy3 (group 0), Cy5 (group II); Microarray 3: Cy3 (group 0), Cy5 (group III); Microarray 4: Cy3 (group 0), Cy5 (group IV); Microarray 5: Cy3 (group I), Cy5 (group II); Microarray 6: Cy3 (group III), Cy5 (group IV).
For the comparison of the expression results from seleniteand selenate-treated rats with that of their companions on Se deficiency, the following criteria were applied:
• only genes with average Cy3 and Cy5 values that were 2-fold above the background were used;
• only genes that were at least 2.5-fold up-or down-regulated by selenite or selenate treatment were considered;
• only genes regulated in an analogous manner by selenite and selenate were considered;
• only genes that fulfilled the statistical assumptions were considered (cf. statistical analysis).
Differentially expressed genes were assigned to five functional areas and are shown in Table 1 :
Area I: genes involved in phase I and phase II detoxification; Area II: genes involved in the regulation of intermediary metabolism and in the regulation of appetite, body weight or other metabolic processes;
Area III: genes related to the cell cycle, cell development, cell death (apoptosis) or tumour metabolism;
Area IV: genes related to inflammatory or immunomodulatory response;
Area V: genes with other functions (e.g. hormonal function, receptor function and signal transduction).
In addition to the examination of the influence of selenite and selenate on differential gene expression compared with Se deficiency, a direct comparison of selenite-and selenate-regulated gene expressions was carried out.
Validation of the MA data for selected differentially expressed genes [GPx1, GPx4, GSTA2 (Alpha2 GST), PTP1B (protein tyrosine phosphatase 1B)] by two-step RT-PCR (reverse transcription-PCR) For GPx1, GPx4, GSTA2 and PTP1B, the validation of the MA data was carried out using two-step RT-PCR. The expression data were normalized to β-actin expression. The twostep RT-PCR method applied was elaborated and refined in our laboratory, and was described in detail previously [22] . New liver RNA pools were prepared for the RT-PCR experiments from the same five rats per group to exclude casual and systematic errors of the MA expression data. The GenBank ® Nucleotide Sequence Database accession numbers, the PCR primers used and the length of the amplificates were as follows. Rat GPx1: NM_030826; forward, TCAT-TGAGAATGTCGCGTCT; reverse, CCCACCAGGAACTTCT-CAAA; amplificate length, 388 bp. Rat GPx4: NM_017165; forward, ATGCACGAATTCTCAGCCAAG; reverse, GGCAG-GTCCTTCTCTAT; amplificate length, 461 bp. Rat GSTA2: NM_0170131; forward, CAGGAGTGGAGTTTGATGAGA; reverse, AGAGGGAAAGAGGTCAGAAG; amplificate length, 463 bp. Rat PTP1B: NM_012637; forward, GCACTTCTGG-GAGATGGTGT; reverse, AAGAGGAAAGACCCGTCCTC; amplificate length, 449 bp. Rat β-actin, NM_0311441; forward, TGTTACCAACTGGGACGACA; reverse, TCTCAGCT-GTGGTGGTGAAG; amplificate length, 396 bp.
Determination of GPx1 and GPx4 activity
The activities of GPx1 and GPx4 were determined spectrophotometrically (Beckmann DU 50) recording glutathione-dependent peroxide reduction coupled with glutathione reductase and NADPH oxidation at 340 nm [29] . For GPx1 activity, the diluted cytosolic supernatants of rat liver homogenates served as sample material. For GPx4 activity, crude homogenates of livers were prepared in a sucrose buffer [30] . H 2 O 2 served as the substrate for GPx1 determination, whereas freshly synthesized PCOOH (phosphatidylcholine hydroperoxide) was used for measurement of GPx4 activity [30] . One unit of GPx1 and GPx4 activities was defined as 1 μmol of NADPH oxidized per min and normalized to 1 mg of protein.
Activity of the phase II detoxification enzymes GSTA2 and epoxide hydrolase
The activity of GSTAs to which GSTA2 activity makes a large contribution was selectively determined according to a spectrophotometric protocol using the specific substrate NBD-Cl (7-chloro-4-nitrobenzoic-2-oxa-1,3-diazole) [31] . The increase in attenuance at 419 nm caused by the conjugation of NBD-Cl to NBD-GSH (7-glutathionyl-4-nitrobenzoic-2-oxa-1,3-diazole) was recorded for 3 min. 1 unit of GSTA2 activity was defined as the formation of 1 μmol of NBD-GSH/min and normalized to 1 mg of protein.
Epoxide hydrolase activity in 1:5 (w/v) crude liver homogenates was measured according to a spectrophotometric protocol using styrene oxide as the substrate [32] . In the first reaction step, 45 μl of the liver homogenates was incubated in 630 μl of 50 mM phosphate buffer containing 10 % DMSO and 10 mmol/l of the substrate styrene oxide for 2 h at 36
• C. This reaction step allows the formation of the vicinal diol from the epoxide by the activity of epoxide hydrolase. Subsequently the samples were treated with 200 μl of 100 mM sodium periodate and 135 μl of 0.8 M sodium sulfite in order to oxidize the vicinal diol to the corresponding aldehyde and to reduce excess sodium periodate to sodium iodide. A 500 μl portion of the supernatant of this reaction was incubated at 70
• C with 50 μl of Schiff's reagent to form a Red Magenta dye. The attenuance was read in a spectrophotometer at 560 nm and compared with a calibration curve prepared with 1-phenyl-1,2-ethanediol. One unit of epoxide hydrolase was defined as the formation of 1 μmol of vicinal diol per min and related to 1 mg of protein.
Statistical analysis
Results are given as means + − S.D. For the enzymatic analyses and for the RT-PCR data, statistical differences between means (P < 0.05) were analysed with 'SPSS 14.0 Table 1 Genes from various functional areas (I-V) differentially regulated in rat liver by feeding selenite and selenate at two dietary levels (0.2 and 1.0 mg/kg) compared with Se deficiency Asterisk indicates that selenite supplementation regulated most genes into the same direction as selenate supplementation (up↑/down↓), but that these effects were not significant (P < 0.05); genes occurring additionally in Table 2 were analysed with the LSD (least significant difference) test if variances were homogeneous or with the Games Howell test otherwise. Changes in gene expression (MA results) were analysed with the Student's t test. At P < 0.05, expression differences were accepted as statistically significant if homogeneous variances and the normality of distribution could be ensured. In order to reduce the genes differentially expressed among treatment groups to a manageable number for publication, only genes that were at least 2.5-fold up-or down-regulated by selenite or selenate treatment were considered (Table 1) . Only genes that were regulated in an analogous manner by selenate at both dietary concentrations or in addition by selenite at one dietary concentration are displayed.
RESULTS
Effect of Se status on feed intake and live weight
After 8 weeks, no significant differences in feed intake and live weight (final average weight 285.8 + − 7.0 g) were observed between rats receiving an Se-deficient diet (0) compared with their littermates with Se-adequate nutrition (I, II) or supranutritive Se supply (III, IV).
Concentration of Se in diets and liver
The basal diet based on Torula yeast was readily accepted by the rats and exhibited an Se concentration below the detection limit ( 
GPx1 and GPx4 activity and expression
As a sensitive parameter of Se deficiency, GPx1 expression and activity were significantly decreased in the Se-deficient group 0 ( Figures 1A and 1C) . Independent of the Se compound, the supplementation with 0.2 mg of Se/kg of diet (groups I and II) resulted in a strong increase in GPx1 activity (73-fold), which was accompanied by multiplied gene expression in the MA experiment (∼7.5-fold). MA results also indicated a marked increase in GPx1 expression (∼6.0-fold) for groups III and IV, which received diets with supranutritive Se (1.0 mg of Se/kg) compared with group 0 ( Figure 1A ). GPx1 activity did not quite reach the level of the adequately supplemented groups (Figure 1C ). The differences in GPx1 mRNA expression, as indicated by the MA data, could be confirmed by two-step RT-PCR analysis ( Figure 1A ). In contrast, only a non-significant weak influence of varying Se supplementation on gene expression of GPx4 was measured. GPx4 responded to Se deficiency only by a non-significant minor down-regulation of its mRNA (1.2-1.6-fold) and by a 1.5-2.0-fold loss of activity ( Figures 1B and 1C) . The mRNA expression data obtained by MA analysis could be confirmed by two-step RT-PCR analysis. No influence of the supplemented Se compound (selenite or selenate) and of the dietary Se level (0.2 and 1.0 mg/kg) on GPx4 expression and activity could be observed.
General results for differential gene expression with regard to the comparison of selenite or selenate feeding compared with Se deficiency
Despite no differences between selenite and selenate in the regulation of the selenoproteins GPx1 and GPx4, the most challenging and unexpected finding in our present study was the fact that compared with Se deficiency (group 0) both dietary selenate levels (groups II and IV) had a distinctly stronger influence on differential gene expression than selenite (groups I and III).
Thus, with a ratio of 2.5 compared with Se deficiency, approx. 300 genes were significantly regulated by selenate feeding, whereas selenite only affected the expression of 43 and 44 genes respectively. For both inorganic Se compounds the comparison of the nutritional level (0.2 mg/kg) and the supranutritive level (1.0 mg/kg) revealed no significant differences in the total number of up-or down-regulated genes.
Specific results for differential gene expression with regard to the comparison of selenite or selenate feeding compared with Se deficiency after mapping functional areas
After analysis of the general effects of selenite and selenate on differential gene expression, we mapped genes that were up-or down-regulated in an analogous manner compared with Se deficiency at least by selenate feeding (242 genes) into five functional areas (cf. the Materials and methods section). The results of this mapping are shown in Table 1 for 44 representative genes. By displaying the regulation ratio as well as the significance level also for the selenite groups I and III, Table 1 clearly shows that selenate feeding (groups II and IV) compared with Se deficiency (group 0) influences the differential expression of genes in all functional areas investigated much more distinctly and significantly than selenite feeding. To confirm the results of the MA analysis, we validated the expression data for three representative target genes (GST2A, area I; epoxide hydrolase, area I; PTP1B, area II) by two-step RT-PCR and/or enzymatic analysis in addition to GPx1 and GPx4 expressions. One very challenging result of our present study was the fact that Se strongly influences the regulation of phase I-and phase II-detoxification genes ( Table 1 , Area I). Three mRNAs of phase II-detoxifying enzymes, namely Afar, GSTA2 and epoxide hydrolase, were distinctly down-regulated by Se feeding (groups I, II, III and IV) compared with Se deficiency (group 0). For these enzymes, selenite feeding was also effective at both dietary levels. We could confirm the validity of the MA data by measurement of GSTA2 expression and activity (Figures 2A and 2B ) and epoxide hydrolase activity ( Figure 2C ). Contrary to the down-regulation of phase II-detoxifying enzymes, the phase I-haemoprotein cytochrome P450c was up-regulated by selenate. In particular by selenate feeding, numerous genes controlling intermediary nutrient metabolism, the regulation of appetite and body weight and other metabolic processes (Table 1, Area II) were differentially regulated compared with Se deficiency. Although selenite feeding influenced the expression of these genes into the same direction, the strength of regulation was not significant in most cases. In the case of haem oxygenase 3 and transferrin receptor, two genes of iron metabolism were distinctly affected in their expression by selenate feeding. The distinct up-regulation of Agouti-related protein precursor, Hypocretin orexin receptor 1, neuropeptide Y precursor and Obreceptor gene-related protein suggests the involvement of Se in central processes of appetite regulation and body weight regulation. Moreover, a distinct influence of Se on carbohydrate and lipid metabolisms was indicated by the regulation of ACAT1 (acyl-CoA:cholesterol acyltransferase 1), fructose-6-phosphate-2-kinase and phosphorylase b kinase. A strong influence of selenate was also observed for the regulation of genes involved in metabolic signal transduction pathways [80-kDa DAG (diacylglycerol) kinase and PTP1B], the regulation of vascular tone (arginase II) and even in folate metabolism (gamma glutamyl hydrolase precursor). In area II the validity of the MA data was confirmed by the examination of the expression and activity of the insulin antagonistic PTP1B (Figure 3) . Thus Se feeding with both selenite and selenate led to a 1.7-2.8-fold up-regulation of PTP1B mRNA, accompanied by a ∼3.0-fold increase in enzyme activity ( Figure 3) .
In Area III (Table 1) , a number of apoptosis-promoting genes such as Bcl-2 antagonist, dermatan sulfate proteoglycan II, Fosrelated antigen, mast cell protease 1, p58 and rapamycin-and FKBP (FK506-binding protein) 12 target 1 were distinctly upregulated by selenate. p58 was also strongly affected by selenite feeding. 
Results for differential gene expression with regard to the direct comparison of selenite and selenate feeding
At a ratio of 2.5 (P < 0.05), a total of 18 genes (3 down-regulated and 15 up-regulated) were found to be differentially expressed by selenate and selenite feeding. Table 2 shows a selection of 11 differentially expressed genes from this comparison. As can be seen from Table 2 , the final ratios originate from different regulatory effects (for details see the Table legend) .
The regulation of the 5-hydroxytryptamine receptor 6 and the growth hormone-releasing hormone receptor β indicates a more pronounced influence of selenate in liver fatty-acid and sterol metabolism as well as in central mechanisms of body weight regulation compared with selenite. The αb crystallin-related protein [also known as HSP20 (heat-shock protein 20)] and its precursor the gcp360 (Golgi-associated protein 360), which are down-regulated during the development of hepatocellular carcinoma, showed a higher expression due to selenate feeding. Both genes were also found to be more highly expressed by selenate in the expression profile when compared with Se deficiency (cf. Table 1 ). The differential regulation of Ly- 49.9 antigen and the inhibitory NK (natural killer) cell receptor Nkr-p1b points to a higher influence of selenate in modulating T-cell response when compared with selenite. The aldo-keto reductase akr1b7, which was up-regulated by selenate compared with selenite, plays an . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . important role in lipid detoxification, in particular in the small intestine. Titin, which increases the elasticity of cardiomyocytes, showed significant up-regulation due to selenate feeding. It was also found to be more highly expressed by selenate in the expression profile compared with Se deficiency (cf. Table 1) . Additional information on functions of the regulated genes in Table 1 and on other selected genes of the functional areas I-V is shown in Supplementary Tables S1-S5 at http://www. bioscirep.org/bsr/030/bsr0300293add.htm. Moreover, the full microarray data sets are available as online supporting material. The assignment of the samples to the six microarrays can be seen from the first sheet in the Excel file containing the data of microarrays 1-3. The second Excel file contains the original data of microarrays 4-6. The red marked columns I and L are the background-corrected expression data for the single genes, which can be used to compare gene expression.
DISCUSSION
In recent years, specific knowledge of the biological effects of Se beyond its role in functional selenoproteins has advanced. Both positive and critical functions of Se with regard to diseases of the Western world such as cancer, cardiac diseases, obesity, insulin resistance, diabetes and hyperlipidaemia have been investigated. To obtain information on cellular mechanisms underlying such specific biological effects of Se, we used MA scanning as the analytical tool. Moreover, we examined the effectiveness of the two inorganic selenocompounds selenite (Se oxidation state IV) and selenate (Se oxidation state +VI) for differential gene expression. In order to produce as distinct effects for Se as possible, we compared the gene expression of Se-supplemented rats with that of their companions during Se deficiency. In addition, a direct comparison of selenite-and selenate-regulated genes was carried out. With regard to the regulation of functional selenoproteins, our results (Table 3 ) are in accord with very recent findings on the influence of Se status on selenoprotein mRNA levels in mice and rats [33] .
The pronounced loss of GPx1 mRNA expression and activity due to Se deficiency and a maximization of both parameters by Se supply at the recommended dietary level (0.2 mg of Se/kg as selenite or selenate, groups I and II) and at a moderate supranutritive supply (1.0 mg of Se/kg as selenite or selenate) confirm the low rank of GPx1 in the hierarchy of selenoproteins. Conversely, the high rank of GPx4 was confirmed by only a small loss of mRNA expression and enzyme activity as well as a low P value for regulation (Table 3 ) due to a lack of dietary Se supply. Our results, moreover, suggest that selenite and selenate are similar in their effectiveness in influencing the expression and activity of GPx1, GPx4 and the expression of further selenoproteins.
The counter-regulation of GPx1 and the phase II detoxification enzymes GSTA2, epoxide hydrolase and Afar (Table 1, Area I) was another central finding of our study. In the literature, a few reports describe similar effects of Se on these so-called xenobiotica metabolizing enzymes. Thus, in a rat trial, an increased aflatoxin toxicity due to Se supplementation was observed, while a moderate Se deficiency effected a distinctly better aflatoxin detoxification based on the up-regulation of the assigned Afar and additionally of GSTA2 [9] . Other studies reported an up-regulation of several GSTs and of epoxide hydrolase in rat liver by Se deficiency. However, recent consolidated findings have shown the underlying mechanism for this phenomenon. In Se deficiency, the transcription of phase II detoxification enzymes increases via the activation of the ARE (antioxidant response element), a DNA structure located upstream of the coding DNA sequence of these enzymes. ARE activation is sensitive to changes in cellular redox status, an increase in peroxide tone, and to interaction with the transcription factor Nrf2 (nuclear factor-erythroid 2-related factor 2). Different GSTs, various aldo-keto reductases, such as Afar, and epoxide hydrolases possess an ARE. In our present study, the up-regulation of phase II detoxification enzymes by Se deficiency and, conversely, the down-regulation with sufficient Se supply were supported by haem oxygenase 3 regulation, representing another enzyme with an ARE in its DNA. That haem oxygenases respond to Se status is confirmed by the results of other trials, in which an up-regulation of haem oxygenase 1 due to a lack of Se supply was reported [10] .
However, a very important and unexpected result of our present study was the finding that selenate feeding related to Se deficiency had a distinctly stronger influence on differential gene expression than selenite.
Fundamental differences in the intestinal absorption pathways, in the blood transport to peripheral organs and in the subsequent intermediary metabolism of selenite (Se oxidation state +IV) and selenate (Se oxidation state +VI) may provide one plausible explanation for this effect [23, 34] . In peripheral organs the absorption products from dietary selenite (oxidation states 0 and -I) need far fewer reduction steps than selenate (oxidation state +VI). In Figures 4(A)-4(C) , possible chemical reactions of selenite and selenate are summarized [17, 35, 36] , which may explain the increased thiol reactivity of dietary selenate in peripheral tissues and represent one essential reason for its greater potential in influencing differential gene expression. The metabolic fates of different Se compounds still need intensive investigation using Se species analysis and protein MS. Antidiabetic and insulinsensitizing effects of Se, restricted exclusively to the intermittent application of very high selenate doses, are based on the inhibition of PTP1B. According to Figures 4B and 4C , selenious acid formation and superoxide anion generation during the peripheral reduction of larger selenate quantities provide a good example of the high reactivity of oral selenate towards cysteine residues in proteins such as PTP1B. For the interpretation of future data from Se studies, one should consider that orally applied selenate mimics properties of selenite applied in cell cultures and in other in vitro studies [11, 17, 23] .
In our present MA experiment, we have analysed a distinct up-regulation of PTP1B mRNA due to Se supplementation at the recommended dietary level and at a slightly supranutritive concentration. PTP1B has recently been discussed as being a promising target in the treatment of obesity, insulin resistance and diabetes. Moreover, the enzyme is involved in growth and development of mammary tumours and in the activation of lipogenesis. Via the reduction of tyrosine phosphorylation of key signalling proteins such as IRS1 and Akt, an increased expression and activity of PTP1B may force the development of insulin resistance, obesity, hyperlipidaemia and diabetes [37, 38] . It may also be critical with regard to the growth of mammary cancer [39] . In contrast, the reduced Akt phosphorylation mediated by increased PTP1B activity through dietary Se supplementation has been investigated as one mechanism explaining possible beneficial Se effects in prostate cancer treatment [12] . With regard to metabolic disorders, recent large cross-sectional studies and Se intervention trials support the PTP1B hypothesis by the finding that a significant positive correlation exists between Se status and the incidence of Type 2 diabetes and increased blood lipids [15, [19] [20] [21] . In this context the detailed regulation of PTP1B by dietary Se has recently been investigated by our group [22] .
The regulation of other genes by selenate feeding (Table 1 , Area II) in particular indicates additional pathways by which Se may promote the development of insulin resistance, obesity, hyperlipidaemia and diabetes besides PTP1B regulation. Both the down-regulation of 80-kDa DAG kinase and the up-regulation of the Agouti-related protein precursor, the hypocretin orexin receptor and of the neuropeptide Y precursor open perspectives for future research concerning the role of Se in metabolic diseases [15, [18] [19] [20] [21] .
As mentioned above, our results for the comparison of Se supplementation compared with Se deficiency suggest a possible preventive mechanism of Se with regard to prostate cancer. Similarly, the regulation of genes involved in growth and differentiation of mammary cancer and lung cancer (ADAMTS-1), of colorectal cancer (PICOT), as well as of various cancer types (proliferin-related protein) indicated a cancer protective function of Se (Table 1 , area III) [40] [41] [42] . However, these effects did not increase by increasing Se supplementation from the recommended dietary amount to the supranutritive level. The comparison of selenite-and selenate-regulated genes indicated a possible additional role of selenate with regard to the prevention of hepatocellular cancer (αb crystalline-related protein/HSP20, Table 2 ) [43] .
Large human intervention trials carried out to investigate the preventive role of long-term Se supplement use in cancer prevention revealed inconsistent results. Thus, in the NPC (nutritional prevention of cancer) study in which 1312 high-risk dermatology patients received 200 μg of Se/day in the form of selenized yeast or a placebo (matched control), a decreased risk of lung, colon, prostate and total cancers was obtained by Se intervention, but an increased risk of non-melanoma skin cancer. In a smaller subtrial of the NPC study in which the participants received even 400 μg of Se/day, the cancer protective effect of the 200 μg dose was lost [16] . In contrast, the SELECT (selenium and vitamin E cancer prevention trial), in which healthy men were supplemented either with 200 μg of Se/day in the form of selenomethionine or with vitamin E (400 IU/day) or with a combination of both supplements compared with a placebo group, was abandoned prematurely in autumn 2008 since the Se-supplemented participants showed a 5 % higher incidence of prostate cancer [15] . Due to the fact that tumour cells frequently possess a changed apoptosis programme, the long-term use of supranutritional Se supplements in cancer prevention and treatment should be reconsidered as well. This position is corroborated by our microarray data indicating both pro-and anti-apoptotic features of Se by modulation of the expression of NAPOR-3, Bcl-2-antagonist 1, Fos-related antigen, granzyme K, mast cell protease and p58 (Table 1 , Area III) [44] [45] [46] [47] [48] [49] . Very recent findings suggest that Se supplementation for cancer prevention is of particular interest for humans with selenoprotein P polymorphisms since this genetic constellation may reduce Se transfer to the peripheral organs and the continued residues in proteins and oxidize them to sulfenic acid derivatives. (5) In the presence of glutathione the sulfenic acid can react to a reversibly inactivated (glutathionylated) protein-thiol compound. The pathways (6), (7) and (8) in selenate metabolism, starting from hydrogen selenide are identical to the pathways (2), (3) and (4) in selenite metabolism. Asterisks in (A) and (B) indicate that, in selenite metabolism, only one pathway leads to the formation of glutathionylated (inactivated) protein intermediates with thiol-group-containing proteins, whereas this modification can be formed by two pathways during selenate metabolism. (C) Evidence for the higher thiol reactivity of selenate compared with selenite from diabetic db/db mice, treated with supranutritional selenite and selenate doses. The higher protein glutathionylation effected by orally applied selenate compared with selenite, marked with* in (A) and (B), can clearly be proven by Western-blot analysis using an 'anti-glutathione antibody'. The Western blot shows a distinctly higher glutathionylation of PTP1B, a protein with a catalytically active cysteine thiol-residue, in db/db mice treated with supranutritional selenate compared with their selenite-treated companions (unpublished results from [17] ). Thus this reaction is clear proof of the higher peripheral thiol reactivity of selenate.
subsequent sufficient synthesis of antioxidant selenoproteins [50] . From the comparison of gene expression related to Se deficiency, our results suggest that Se and, in particular, selenate is effective in influencing many other genes in the mammalian organism. Thus the regulation of genes that are also expressed in the liver and have specific functions for the integrity of the heart muscle and the skeletal muscle [e.g. cardiac ankyrin repeat protein, fibroblast growth factor 13, GDNF (glial-derived neurotrophic factor) receptor β, μ-calpain large subunit, TIMP-3, Titin and wingless-type MMTV (murine-mammary-tumour virus integration site family) [51] [52] [53] [54] [55] [56] may help in gaining new insights into the beneficial effects of Se in the prevention of muscular dystrophy (Table 1 , Area V). Similarly, the established effectiveness of Se in preventing liver necrosis is supported by the upregulation of αVIIc integrin, mitogen-activated protein kinase 12 ZPK (mitogen-activated protein kinase kinase kinase 12), Plectin 1 ( Table 1 , Area III) and of CREB1 (Table 1 , Area V) [57] [58] [59] [60] .
The direct comparison of selenite-and selenate-regulated genes revealed additional effects of selenate, e.g. in liver fattyacid and sterol metabolism and in central mechanisms of body weight regulation (5-hydroxytryptamine receptor 6 and growth hormone-releasing hormone receptor β) [61] , in the protection against hepatocellular carcinoma (αb crystallin-related protein/HSP20), in the modulation of T-cell response (Ly- 49.9 antigen and the inhibitory NK cell receptor Nkr-p1b) and in the protection against lipid toxicity (aldo-keto reductase akr1b7) [43, 62] .
In summary, our present study on the effects of the two common inorganic Se compounds selenite and selenate on the differential expression of genes other than selenoproteins showed the following.
Compared with Se deficiency as a control, selenite (Se oxidation state + VI) and selenate (Se oxidation state + VI) resembled each other in their effectiveness for selenoprotein synthesis. Both Se compounds could be demonstrated to be equally effective in the down-regulation of not less than three enzymes of phase II detoxification and of a further gene with an ARE in its DNA (Afar, epoxide hydrolase, GSTA2 and haem oxygenase 3). This result demonstrates mechanisms of counter-regulation of antioxidant enzymes.
Compared with Se deficiency, selenate has a distinctly stronger influence than selenite on differential gene expression in various functional areas. This distinct difference, so far unknown, may result from fundamental differences in the absorption and the intermediary metabolism of both Se compounds. This remarkable difference for both Se compounds should be considered in future investigations into Se biochemistry.
The direct comparison of selenite-and selenate-regulated genes revealed additional functions of selenate in liver fatty-acid and sterol metabolism and in central mechanisms of body weight regulation, in the protection against hepatocellular carcinoma, in the modulation of T-cell response and in the protection against lipid toxicity (aldo-keto reductase akr1b7).
In view of the distinct influence of Se on differential gene expression, our results could contribute to an improved understanding of mechanisms by which Se may influence diseases of the Western world. Other genes differentially regulated by selenate provide deeper insights into the beneficial effects of Se in preventing Se-deficiency symptoms such as muscular dystrophy and liver necrosis.
We conclude that future studies on the pathways of Se in the treatment of diseases should consider the particular effects of the Se compound used and that the compilation of comparative differential gene expression profiles for further Se compounds would be of interest.
Impact of selenite and selenate on differentially expressed genes in rat liver examined by microarray analysis 
